Atlas Trials

Oral Lactobacillus Crispatus Lc-G22 as Adjunctive Therapy for Vulvovaginal Candidiasis

Clinical trial NCT07727967 · COMPLETED

Trial details

NCT number
NCT07727967
Sponsor
BioGrowing Co., Ltd
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Vulvovaginal Candidiasis
Start date
2022-07-01
Primary completion
2023-12-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.